Nanjing Vishee Medical Stock Revenue
| 688580 Stock | 29.96 0.29 0.98% |
Nanjing Vishee Medical fundamentals help investors to digest information that contributes to Nanjing Vishee's financial success or failures. It also enables traders to predict the movement of Nanjing Stock. The fundamental analysis module provides a way to measure Nanjing Vishee's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nanjing Vishee stock.
Nanjing |
Nanjing Vishee Medical Company Revenue Analysis
Nanjing Vishee's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Nanjing Vishee Revenue | 462.22 M |
Most of Nanjing Vishee's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nanjing Vishee Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Nanjing Vishee Medical reported 462.22 M of revenue. This is 93.94% lower than that of the Health Care Equipment & Supplies sector and 81.88% lower than that of the Health Care industry. The revenue for all China stocks is 95.1% higher than that of the company.
Nanjing Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nanjing Vishee's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nanjing Vishee could also be used in its relative valuation, which is a method of valuing Nanjing Vishee by comparing valuation metrics of similar companies.Nanjing Vishee is currently under evaluation in revenue category among its peers.
Nanjing Fundamentals
| Return On Equity | 0.0704 | |||
| Return On Asset | 0.0332 | |||
| Profit Margin | 0.27 % | |||
| Operating Margin | 0.30 % | |||
| Current Valuation | 1.84 B | |||
| Shares Outstanding | 95.77 M | |||
| Shares Owned By Insiders | 70.64 % | |||
| Shares Owned By Institutions | 2.76 % | |||
| Price To Book | 1.78 X | |||
| Price To Sales | 6.80 X | |||
| Revenue | 462.22 M | |||
| Gross Profit | 321.62 M | |||
| EBITDA | 113.44 M | |||
| Net Income | 136.26 M | |||
| Total Debt | 179.27 M | |||
| Book Value Per Share | 16.97 X | |||
| Cash Flow From Operations | 134.2 M | |||
| Earnings Per Share | 1.18 X | |||
| Target Price | 36.97 | |||
| Number Of Employees | 700 | |||
| Beta | 0.27 | |||
| Market Capitalization | 2.87 B | |||
| Total Asset | 1.81 B | |||
| Retained Earnings | 438.42 M | |||
| Working Capital | 1.1 B | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 1.81 B | |||
| Last Dividend Paid | 1.08 |
About Nanjing Vishee Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nanjing Vishee Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nanjing Vishee using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nanjing Vishee Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Nanjing Stock
Nanjing Vishee financial ratios help investors to determine whether Nanjing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanjing with respect to the benefits of owning Nanjing Vishee security.